256 related articles for article (PubMed ID: 15048610)
41. Clinical characteristics associated with different strengths of loudness dependence of auditory evoked potentials (LDAEP) in major depressive disorder.
Min JA; Lee SH; Lee SY; Chae JH; Lee CU; Park YM; Bae SM
Psychiatry Res; 2012 Dec; 200(2-3):374-81. PubMed ID: 23021319
[TBL] [Abstract][Full Text] [Related]
42. An examination of acute changes in serotonergic neurotransmission using the loudness dependence measure of auditory cortex evoked activity: effects of citalopram, escitalopram and sertraline.
Guille V; Croft RJ; O'Neill BV; Illic S; Phan KL; Nathan PJ
Hum Psychopharmacol; 2008 Apr; 23(3):231-41. PubMed ID: 18196604
[TBL] [Abstract][Full Text] [Related]
43. Loudness dependence of the auditory evoked N1/P2 component as an indicator of serotonergic dysfunction in patients with schizophrenia--a replication study.
Juckel G; Gudlowski Y; Müller D; Ozgürdal S; Brüne M; Gallinat J; Frodl T; Witthaus H; Uhl I; Wutzler A; Pogarell O; Mulert C; Hegerl U; Meisenzahl EM
Psychiatry Res; 2008 Feb; 158(1):79-82. PubMed ID: 18096246
[TBL] [Abstract][Full Text] [Related]
44. The challenge of predicting response to stabilising lithium treatment. The importance of patient selection.
Grof P; Alda M; Grof E; Fox D; Cameron P
Br J Psychiatry Suppl; 1993 Sep; (21):16-9. PubMed ID: 8217062
[TBL] [Abstract][Full Text] [Related]
45. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
Revicki DA; Hirschfeld RM; Ahearn EP; Weisler RH; Palmer C; Keck PE
J Affect Disord; 2005 Jun; 86(2-3):183-93. PubMed ID: 15935238
[TBL] [Abstract][Full Text] [Related]
46. Low serotonergic function and its normalization by treatment with sertraline in obsessive-compulsive disorder--an auditory evoked potential study.
Mavorgiorgou P; Gohle D; Winter C; Rujescu D; Pogarell O; Mulert C; Bär KJ; Zaudig M; Hegerl U; Juckel G
J Clin Psychopharmacol; 2010 Jun; 30(3):341-3. PubMed ID: 20473079
[No Abstract] [Full Text] [Related]
47. Affective disorders and the loudness dependence of the auditory evoked potential: Serotonin and beyond.
Fitzgerald PJ
Neurosci Lett; 2024 Mar; 827():137734. PubMed ID: 38499279
[TBL] [Abstract][Full Text] [Related]
48. Impact of loudness dependency of auditory evoked potentials on the panic response to CCK-4.
Eser D; Leicht G; Baghai T; Pogarell O; Schüle C; Karch S; Nothdurfter C; Rupprecht R; Mulert C
J Psychiatr Res; 2009 Jan; 43(4):393-400. PubMed ID: 18534623
[TBL] [Abstract][Full Text] [Related]
49. [Mechanism and clinical effects of drugs for mood disorder].
Nakagawa S; Koyama T
Ryoikibetsu Shokogun Shirizu; 2003; (38):358-61. PubMed ID: 12877002
[No Abstract] [Full Text] [Related]
50. Evidence for sex differences in the loudness dependence of the auditory evoked potential in humans.
Oliva JL; Leung S; Croft RJ; O'Neill BV; Stout JC; Nathan PJ
Hum Psychopharmacol; 2011 Mar; 26(2):172-6. PubMed ID: 21455974
[TBL] [Abstract][Full Text] [Related]
51. Dopamine D1 receptor gene polymorphism is associated with prophylactic lithium response in bipolar disorder.
Rybakowski JK; Dmitrzak-Weglarz M; Suwalska A; Leszczynska-Rodziewicz A; Hauser J
Pharmacopsychiatry; 2009 Jan; 42(1):20-2. PubMed ID: 19153942
[TBL] [Abstract][Full Text] [Related]
52. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
[TBL] [Abstract][Full Text] [Related]
53. Response to prophylactic lithium in bipolar disorder may be associated with a preservation of executive cognitive functions.
Rybakowski JK; Permoda-Osip A; Borkowska A
Eur Neuropsychopharmacol; 2009 Nov; 19(11):791-5. PubMed ID: 19577437
[TBL] [Abstract][Full Text] [Related]
54. Long-term stability of cognitive impairment in bipolar disorder: a 2-year follow-up study of lithium-treated euthymic bipolar patients.
Mur M; Portella MJ; Martínez-Arán A; Pifarré J; Vieta E
J Clin Psychiatry; 2008 May; 69(5):712-9. PubMed ID: 18435565
[TBL] [Abstract][Full Text] [Related]
55. Lithium in the prophylactic treatment of recurrent affective disorders.
Kua EH; Lee SL; Chee KT
Singapore Med J; 1982 Oct; 23(5):262-4. PubMed ID: 7157005
[No Abstract] [Full Text] [Related]
56. Response prediction to antidepressants using scalp and source-localized loudness dependence of auditory evoked potential (LDAEP) slopes.
Jaworska N; Blondeau C; Tessier P; Norris S; Fusee W; Blier P; Knott V
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():100-7. PubMed ID: 23360662
[TBL] [Abstract][Full Text] [Related]
57. Association between Cortical GABA and Loudness Dependence of Auditory Evoked Potentials (LDAEP) in Humans.
Wyss C; Tse DHY; Boers F; Shah NJ; Neuner I; Kawohl W
Int J Neuropsychopharmacol; 2018 Sep; 21(9):809-813. PubMed ID: 29917080
[TBL] [Abstract][Full Text] [Related]
58. An initial report of a new biological marker for bipolar disorder: P85 evoked brain potential.
Patterson JV; Sandman CA; Ring A; Jin Y; Bunney WE
Bipolar Disord; 2009 Sep; 11(6):596-609. PubMed ID: 19689502
[TBL] [Abstract][Full Text] [Related]
59. Influence of levothyroxine in augmentation therapy for bipolar depression on central serotonergic function.
Uhl I; Bez JA; Stamm T; Pilhatsch M; Assion HJ; Norra C; Lewitzka U; Schlagenhauf F; Bauer M; Juckel G
Pharmacopsychiatry; 2014 Jul; 47(4-5):180-3. PubMed ID: 25002290
[TBL] [Abstract][Full Text] [Related]
60. Interaction of estrogen with central serotonergic mechanisms in human sensory processing: loudness dependence of the auditory evoked potential and mismatch negativity.
Guille V; Gogos A; Nathan PJ; Croft RJ; van den Buuse M
J Psychopharmacol; 2011 Dec; 25(12):1614-22. PubMed ID: 20562170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
